Here’s the latest news piece to cite 100 Plus. The author interviewed some naysayers on the topic of healthspan, but ultimately I think it’s clear that if Silicon Valley can figure out how to increase human health, that is a good thing for everyone.
Researchers at Duke University have engineered a polio virus to infect cancer cells. This weakens the cancer and alerts the body’s immune system to the fact that there is something growing in the body that shouldn’t be there. It’s brilliant work and 60 Minutes has done a great job of capturing the story. Watch it here.
Here’s the story from Forbes.
“The company has hired Richard Scheller, who led drug discovery at biotech icon Genentech for 14 years before announcing he would retire in December, and who has won some of science’s top awards, including the Lasker Prize, often referred to as “America’s Nobel,” and the Kavli Prize.”
From the Independent:
“A new class of drugs has been identified that slow the ageing process in mice, alleviating symptoms of frailty and extending a healthy lifespan.
If their effect on humans is as marked as it is on animal models, their benefit could be enormous.
The research was carried out by a team from Mayo Clinic, The Scripps Institute and other institutions and published in the journal Aging Cell yesterday.
“We view this study as a big, first step toward developing treatments that can be given safely to patients to extend healthspan or to treat age-related diseases and disorders,” said co-lead author and TSRI Professor Paul Robbins, PhD.”
Please tune in to Sirius XM (Channel 121) this Saturday at 9am PT (12pm ET) to listen to a longevity discussion between me and Dr. Anthony Atala of Wake Forest Institute for Regenerative Medicine.
This is such a great story, and really only the beginning of what will be possible outside of the traditional health sector. Thank-you awesome engineers and tinkerers!
Also, see this adorable video of Robert Downey Jr. helping out with the cause.
It was a pleasure to meet Dr. Craig Venter at Stanford this week. As you can imagine, he had strong views and a huge amount of energy. I’m super-interested in all of his work, but was surprised to find out about his efforts to fight the spread of influenza using genomics. He convinced me that it is possible to create an annual flu vaccine that actually targets the flu of that year. That would be useful.
I spent last weekend at Wake Forest University in NC at their annual TedX event. It was a great group of people, and I’m looking forward to posting links to all the talks when they are released.
A great story. And another example of how man is blending with machine.
From the NY Daily News:
“Zderad became the 15th person in the country, and the first in his home state, to receive the implanted sight device created by Second Sight, Inc., according to the Mayo Clinic.
The tiny implant works by sending light waves to the optic nerve, bypassing the damaged retina. Wires attach to a prosthetic device that looks like sunglasses and renders a certain amount of imagery.”
An interesting new way to study diseases of the brain. From MIT Tech Review:
“A new method for growing human brain cells could unlock the mysteries of dementia, mental illness, and other neurological disorders.”
Lots of people I know will be interested in this. Here’s the story from the researchers at Sanford-Burnham.
“We have developed a method using human pluripotent stem cells to create new cells capable of initiating human hair growth. The method is a marked improvement over current methods that rely on transplanting existing hair follicles from one part of the head to another,” said Alexey Terskikh, Ph.D., associate professor in the Development, Aging, and Regeneration Program. “Our stem cell method provides an unlimited source of cells from the patient for transplantation and isn’t limited by the availability of existing hair follicles.”
“Wyss-Coray formed a start-up company, Alkahest in Menlo Park, California, and in September 2014 it began a randomized, placebo-controlled, double-blind trial at Stanford, testing the safety and efficacy of using young plasma to treat Alzheimer’s disease. Six out of a planned 18 people with Alzheimer’s, all aged 50 or above, have already begun to receive plasma harvested from men aged 30 or younger. In addition to monitoring disease symptoms, the researchers are looking for changes in brain scans and blood biomarkers of the disease.”
And from Stanford Medicine:
“Something — or some things — in the blood of young mice has the ability to restore mental capabilities in old mice, a new study by Stanford University School of Medicine investigators has found.
If the same goes for humans, it could spell a new paradigm for recharging our aging brains, and it might mean new therapeutic approaches for treating dementias such as Alzheimer’s disease.”
Here are two well-written stories about longevity, the Palo Alto Longevity Prize, and my book, 100 Plus. Journalist Joshua Alvarez did a good job interviewing a diverse set of voices. Here are the two links: one and two.
A few observations:
-Some may be surprised to see that the head of Stanford’s “Center on Longevity” says that “I’m largely on the fence about increasing lifespan. I see a real need for improving the quality of our lives and accommodating the years we’ve been given.” That’s sort of depressing, particularly given that so much of the cool tech that will extend our health is being created right at Stanford.
-I’m happy to have been given credit for writing the book that Dr. Walter Bortz, a physician who advocates for a 100 year lifespan, thought would never be written.
From Singularity Hub:
““No, no it’s not science fiction; it’s already happening,” said Ido Bachelet to a somewhat incredulous audience member at a London event late last year. Bachelet, previously of Harvard’s Wyss Institute and faculty member at Israel’s Bar-Ilan University, is a leading figure in the field of DNA nanotechnology.
In a brief talk, Bachelet said DNA nanobots will soon be tried in a critically ill leukemia patient. The patient, who has been given roughly six months to live, will receive an injection of DNA nanobots designed to interact with and destroy leukemia cells—while causing virtually zero collateral damage in healthy tissue.
According to Bachelet, his team have successfully tested their method in cell cultures and animals and written two papers on the subject, one in Science and one in Nature.”
The upshot is that “Brain cells called microglia chew up toxic substances and cell debris, calm inflammation and make nerve-cell-nurturing substances. New research shows that keeping them on the job may prevent neurodegeneration.”
From the NYT:
“We all know that exercise can make us fitter and reduce our risk for illnesses such as diabetes and heart disease. But just how, from start to finish, a run or a bike ride might translate into a healthier life has remained baffling.
Now new research reports that the answer may lie, in part, in our DNA. Exercise, a new study finds, changes the shape and functioning of our genes, an important stop on the way to improved health and fitness.”
“How old do you feel? Think carefully – the answer might help predict how much longer you’ll live. That’s according to British research posing that question to about 6,500 adults. Those who felt younger than their real age lived the longest over the following eight years.”